摘要
目的 :观察动脉灌注化疗及栓塞治疗原发性肝癌的疗效。方法 :采用肝动脉插管灌注化疗及栓塞治疗 10 6例病人 ,4～ 6周 1次 ,共进行 4 6 3次 ,最多 6次 ,最少 2次。结果 :CR +PR占 58.5% ,1、2、3年生存率分别为 6 0 .4 %、4 0 .6 %、2 6 .4 %。结论 :采用动脉灌注化疗及栓塞术 ,对拒绝手术或失去手术机会的原发性肝癌患者是一种有效的治疗方法。
Objective:The theraputic effect of transcatheter arterial infusion chemoembolization(TACE)to Primary liver cancer Methods:TACE was given to the patients once every 4-6 weeks,106 patients received 463 times TACE,the most 6 times,the least 2 times Results:CR+PR accounted for 58.5% 1-,2-,3-year survival rate were 60.4%,40.6%,26.4%,respectively Conclusions:To the patients of primary liver cancer who rejected operation and the patients who had lost the chance of operation,TACE would be an effective way of treatment
出处
《肿瘤防治杂志》
2000年第2期160-161,共2页
China Journal of Cancer Prevention and Treatment
关键词
原发性肝癌
动脉灌注
栓塞治疗
化疗药物
primary liver cancer
transcatheter arterial chemotherapy
transcatheter arterial embolization
chemotherapy drug
